Alternatives to Sinopia Biosciences

Sinopia Biosciences is a Biotechnology tool: biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform. Here are the 60 closest alternatives, compared on pricing, features and what real users say.

Sinopia Biosciences profile Open source alternatives (18)More Biotechnology alternatives

The 20 closest Biotechnology companies to Sinopia Biosciences

Website
NantHealth54
HealthTechCulver City, United States
NantHealth provides a suite of healthcare solutions focused on precision medicine and data analytics.
Website
BioAge Labs53
BiotechNew Haven, United States
BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.
Website
Genedata27
BioinformaticsBasel, Switzerland
Enterprise software solutions for biopharmaceutical R&D, accelerating drug discovery and development.
Website
Moderna77
BiotechnologyCambridge, United States$4.5B
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Website
Infinimmune60
BiotechnologyAlameda, United States$75.0M
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Website
LifeMine Therapeutics Inc.60
BiotechnologyWatertown, United States$543.0M
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Website
CellCentric60
BiotechnologyCambridge, United Kingdom$375.0M
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
EA
Earendil Labs56
BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
Website
Transcripta Bio54
BiotechnologyPalo Alto, United States$24.0M
AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.
Website
ImmunityBio44
BiotechnologyCulver City, USA$75.0M
A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Website SI
Sightera Biosciences43
BiotechnologyAntwerp, Belgium$3.0M
AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.
Website
BioNTech66
BiotechnologyMainz, Germany$975.0M
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Website
Degron Therapeutics62
BiotechnologySan Diego, USA$40.0M
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Website
Epicrispr Biotechnologies62
BiotechnologySouth San Francisco, United States$90.0M
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Website
Pixelgen Technologies62
BiotechnologyStockholm, Sweden$43.5M
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Website
Adcendo60
BiotechnologyCopenhagen, Denmark$272.0M
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Website
Network Bio60
BiotechnologyPalo Alto, United States$100.0M
Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
Website
Enterome60
BiotechnologyParis, France$123.9M
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Website
4D Path59
BiotechnologyNewton, USA$17.4M
Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
Website
BreezeBio58
BiotechnologyAlameda, US$93.5M
BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Company	Sector	HQ	Funding	Score	Website
NantHealthNantHealth provides a suite of healthcare solutions focused on precision medicine and data analytics.	HealthTech	Culver City, United States	—	54	Website
BioAge LabsBioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.	Biotech	New Haven, United States	—	53	Website
GenedataEnterprise software solutions for biopharmaceutical R&D, accelerating drug discovery and development.	Bioinformatics	Basel, Switzerland	—	27	Website
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	Biotechnology	Cambridge, United States	$4.5B	77	Website
InfinimmuneDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.	Biotechnology	Alameda, United States	$75.0M	60	Website
LifeMine Therapeutics Inc.Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.	Biotechnology	Watertown, United States	$543.0M	60	Website
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.	Biotechnology	Cambridge, United Kingdom	$375.0M	60	Website
EAEarendil LabsEarendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.	Biotechnology	Beijing, China	$787.0M	56
Transcripta BioAI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.	Biotechnology	Palo Alto, United States	$24.0M	54	Website
ImmunityBioA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.	Biotechnology	Culver City, USA	$75.0M	44	Website
SISightera BiosciencesAI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.	Biotechnology	Antwerp, Belgium	$3.0M	43	Website
BioNTechGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.	Biotechnology	Mainz, Germany	$975.0M	66	Website
Degron TherapeuticsClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.	Biotechnology	San Diego, USA	$40.0M	62	Website
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).	Biotechnology	South San Francisco, United States	$90.0M	62	Website
Pixelgen TechnologiesA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.	Biotechnology	Stockholm, Sweden	$43.5M	62	Website
AdcendoDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.	Biotechnology	Copenhagen, Denmark	$272.0M	60	Website
Network BioLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.	Biotechnology	Palo Alto, United States	$100.0M	60	Website
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.	Biotechnology	Paris, France	$123.9M	60	Website
4D PathPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.	Biotechnology	Newton, USA	$17.4M	59	Website
BreezeBioBreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.	Biotechnology	Alameda, US	$93.5M	58	Website

Showing the 20 closest matches. See the rest on the Sinopia Biosciences profile.

Compare Sinopia Biosciences head to head

Side by side on what each one does, what it costs, and what real users report.